| 注册
首页|期刊导航|中国药房|米氮平联合西酞普兰治疗抑郁症患者睡眠障碍的临床观察

米氮平联合西酞普兰治疗抑郁症患者睡眠障碍的临床观察

顾翠 可秦 张平 师梦

中国药房2017,Vol.28Issue(5):670-673,4.
中国药房2017,Vol.28Issue(5):670-673,4.DOI:10.6039/j.issn.1001-0408.2017.05.26

米氮平联合西酞普兰治疗抑郁症患者睡眠障碍的临床观察

Clinical Observation of Mirtazapine Combined with Citalopram in the Treatment of Sleep Disorder of De-pressive Patients

顾翠 1可秦 1张平 1师梦1

作者信息

  • 1. 玉溪市人民医院神内一科,云南玉溪 653100
  • 折叠

摘要

Abstract

OBJECTIVE:To investigate the clinical efficacy and safety of mirtazapine combined with citalopram in the treat-ment of sleep disorder in depressive patients. METHODS:One hundred and sixty-five depressive patients with sleep disorder were selected and divided into control group (82 cases) and treatment group (83 cases) according to random number table. Control group took Escitalopram oxalate tablet 10 mg,once every night,increasing to 20 mg according to disease condition;treatment group was additionally given Mirtazapine tablet 15 mg,once every night,increasing to 30 mg one week later. Both groups re-ceived treatment for consecutive 6 months. HAMD-17 and MADRS were observed in 2 groups before and after treatment,and the sleep quality of 2 groups were evaluated by PSQI before and after treatment;the sleep structure was measured by using polysom-nography before and after treatment;clinical efficacies and the occurrence of ADR were compared between 2 groups. RESULTS:Before treatment,there was no statistical significance in HAMD-17,MADRS and PSQI score,sleep structure between 2 groups (P>0.05);after treatment,above scores and indexes of 2 groups were all improved significantly,and the treatment group was sig-nificantly better than the control group,with statistical significance(P<0.05). Total response rate of treatment group was 97.47%, which was significantly higher than 78.95%of control group,with statistical significance(P<0.05). There was no statistical signif-icance in the incidence of ADR between 2 groups(P>0.05). CONCLUSIONS:Citalopram combined with mirtazapine shows sig-nificant therapeutic efficacy for sleep disorder of depressive patients,and can significantly improve sleep structure,adjust sleep cy-cle and improve sleep quality with good safety.

关键词

西酞普兰/米氮平/抑郁症/睡眠障碍/临床疗效/安全性

Key words

Citalopram/Mirtazapine/Depression/Sleep disorder/Clinical efficacy/Safety

分类

医药卫生

引用本文复制引用

顾翠,可秦,张平,师梦..米氮平联合西酞普兰治疗抑郁症患者睡眠障碍的临床观察[J].中国药房,2017,28(5):670-673,4.

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文